title: Targeted Cancer Therapy: Class Related Toxicities.
authors.forename: Nayon
authors.initials: N
authors.lastname: Kang
authors.forename: Nicholas
authors.initials: N
authors.lastname: Forcello
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000145:classification; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors; D006801:Humans; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D000970:Antineoplastic Agents; D042461:Vascular Endothelial Growth Factor A; C546842:MTOR protein, human; D066246:ErbB Receptors; D016044:Fusion Proteins, bcr-abl; D058570:TOR Serine-Threonine Kinases